Over 580,000 bottles of blood pressure medication have been recalled by the FDA due to elevated levels of a potential carcinogenic impurity.
The recall affects certain lots of prazosin hydrochloride capsules, specifically 1mg, 2mg, and 5mg bottles, which can be identified by lot number and expiration date.
No one wants to trade high blood pressure for a potentially cancer-causing chemical
According to the FDA Enforcement Report, the affected bottles were manufactured by Teva Pharmaceuticals in New Jersey.
It is essential to consult a physician before stopping any medication, even if the bottles are affected by the recall.
Affected bottles can be identified by checking the lot number and expiration date as outlined in the FDA report.
Author's summary: FDA recalls blood pressure medication due to carcinogenic impurity.